Causes of Slightly Elevated Norepinephrine
Slightly elevated norepinephrine levels most commonly result from physiological stress, inappropriate sampling conditions (not supine for 30 minutes), medication interference, or early/mild pathological states including cardiovascular disease, cirrhosis, early hypertension, or small catecholamine-secreting tumors.
Algorithmic Approach to Interpretation
First: Rule Out Technical and Physiological Causes
Sampling conditions are critical - blood must be drawn after the patient has been fully recumbent for at least 30 minutes 1. Failure to follow this protocol is the most common cause of borderline elevations and affects approximately 25% of patients with pheochromocytomas/paragangliomas (PPGLs) who have borderline results 1.
Key technical considerations:
- Medication interference: Tricyclic antidepressants, acetaminophen, mesalamine, and sulfasalazine can cause mildly to markedly raised values 1
- Physiological stress: Extreme illness, intensive care settings, and acute medical conditions elevate norepinephrine 1
- Laboratory error: Should always be considered with unexpected results 1
Second: Consider Cardiovascular Pathology
In primary hypertension, particularly in patients under 40 years old, norepinephrine secretion rates are elevated (mean 418 ng/min vs 294 ng/min in normotensive subjects) 2. The elevation is selective, with increased sympathetic outflow specifically to the kidneys and heart in early hypertension 2.
In congestive heart failure, elevated plasma norepinephrine (4.18 nmol/L vs 1.54 nmol/L in controls) results from increased secretion rates rather than decreased clearance 3. This occurs even in moderate low-output cardiac failure and reflects compensatory sympathetic activation in response to diminished effective arterial blood volume 3.
Third: Evaluate for Hepatic Disease
Decompensated cirrhosis produces markedly elevated norepinephrine (830 pg/mL vs 185 pg/mL in controls) due to increased secretion rates (1.50 vs 0.26 μg/m²/min), not decreased clearance 4. These elevations correlate inversely with urinary sodium and water excretion and are suppressible by central blood volume expansion 4.
Fourth: Consider Catecholamine-Secreting Tumors
For PPGLs, norepinephrine production is defined by elevation in plasma and/or urine normetanephrine 5. Critical thresholds:
- Clinically significant secretion: ≥2-fold the upper reference limit of normetanephrine with hyperadrenergic symptoms (palpitations, tachycardia, diaphoresis, tremors, new-onset hypertension) 5
- Borderline elevations: Require follow-up with clonidine suppression testing (97% sensitivity, purported 100% specificity) or wait-and-retest approach over 6+ months 1
Blood pressure patterns correlate with catecholamine type and level 6:
- High norepinephrine (≥10× normal): sustained hypertension
- Moderate-to-high epinephrine (≥5× normal): paroxysmal hypertension
- Levels <10× normal: often normotensive
Common Pitfalls
Never initiate imaging before biochemical confirmation - imaging should only begin once there is clear biochemical evidence of a PPGL 1
Avoid repeat testing during acute illness - physiological stress in intensive care settings produces false elevations 1
Do not overlook medication history - many common medications interfere with catecholamine measurements 1
For borderline elevations with low clinical suspicion: Adopt a wait-and-retest approach rather than immediate extensive workup, as continued increases over 6+ months suggest an enlarging tumor 1
In dopamine-only producing tumors (isolated elevation of plasma methoxytyrosine), patients are typically normotensive or hypotensive, and alpha-blockade is not indicated 5